This document provides information about a continuing education event on COVID-19 vaccination strategies for youth. It begins by outlining the accreditation of the event for various healthcare professionals. The event will feature a COVID-19 update, discussions on vaccinating children ages 12-15 and considerations for co-administering other vaccines. Presenters will include an infectious disease specialist, public school superintendent, health center representatives. Attendees can complete a survey to request continuing education credits for viewing the event live or recorded.

1. COVID-19 Vaccination Strategies for
Youth
May 19, 2021

2. Continuing Education Credits
In support of improving patient care, Community Health Center,
Inc./Weitzman Institute is jointly accredited by the Accreditation Council
for Continuing Medical Education (ACCME), the Accreditation Council for
Pharmacy Education (ACPE), and the American Nurses Credentialing
Center (ANCC), to provide continuing education for the healthcare team.
This designation confers simultaneous continuing education
accreditation across nine national accrediting bodies.
This series is intended for physicians, nurse practitioners, nurses,
physician assistants, psychologists, clinical social workers, dentists,
pharmacists, and dietitians.
Please complete the survey – linked in the chat, and emailed to all
attendees – to request your continuing education credit for live viewing.
A comprehensive certificate will be sent out at the end of the series.

3. Disclosure
• With respect to the following presentation, there has been no relevant
(direct or indirect) financial relationship between the parties listed above
(or spouse/partner) and any for-profit company in the past 12 months
which would be considered a conflict of interest.
• The views expressed in this presentation are those of the presenter and
may not reflect official policy of Community Health Center, Inc. and its
Weitzman Institute.
• We are obligated to disclose any products which are off-label, unlabeled,
experimental, and/or under investigation (not FDA approved) and any
limitations on the information hat I present, such as data that are
preliminary or that represent ongoing research, interim analyses, and/or
unsupported opinion.

4. COVID-19 Update in the United States
May 19, 2021
Stephen Scholand, MD
Infectious Disease Specialist, Midstate Medical Center
www.ohtorch.com/

5. 32,996,503 cases on 5/18/21 with 587,196 deaths
COVID-19 in the United States
https://coronavirus.jhu.edu/us-map

6. https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html
We are
winning!

7. www.nytimes.com
Hot spots around the USA

8. How many ‘jet liners’? A320 seats 182 passengers

9. Pressure on hospital systems
https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html

10. The danger of variants
• Variants of Interest
B.1.525, B.1.526, P.2
B.1.617 (India)
• Variants of concern
B.117, B1.351, P.1
B.1.427 and B.1.429 (first detected in California)
• Variants of High Consequence
Thankfully none – yet!
www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-
surveillance/variant-info.html#Interest

11. COVID-19 Vaccinations across the Nation
https://covid.cdc.gov/covid-data-tracker/#vaccinations

12. https://covid.cdc.gov/covid-data-tracker/#vaccinations

13. Children and COVID-19 vaccines
• The CDC has recommended Pfizer/BioNTech
vaccine for children ages 12 to 15
– estimated efficacy of 100% in preventing COVID-19
– Side effects after vaccination ~ 90% local and/or
systemic reaction) –but mild to moderate
• Pain at the injection site
• fever, fatigue, HA, muscle pain more common after the 2nd
dose
– Similar to aged ≥16 years
• No specific safety concerns identified
• Children may be the key to reaching herd
immunity

14. CDC: Children and COVID-19 vaccines
• COVID-19 vaccines and other vaccines may now
be administered without regard to timing
• Simultaneous administration of COVID-19
vaccines and other vaccines on the same day
– Unknown whether reactogenicity of COVID-19 vaccine
is increased with coadministration
– Consider: whether the patient is behind schedule, at
risk of vaccine-preventable disease (e.g., outbreak or
occupational exposures), and the reactogenicity
profile of the vaccines [live vaccines, adjuvanted]

15. Trusted Resources
• Nuvance health 2600+ articles reviewed:
https://spark.adobe.com/page/x5sxhnZwbKqlc/
• CDC:
https://www.cdc.gov/coronavirus/2019-ncov/index.html
https://emergency.cdc.gov/coca/calls/2021/
• WHO:
https://www.who.int/emergencies/diseases/novel-coronavirus-2019
• Johns Hopkins:
https://coronavirus.jhu.edu/map.html
• Others
https://www.thelancet.com/coronavirus
https://covidactnow.org/

16. COVID-19 Vaccination Strategies
for Youth
Nathan Quesnel
Superintendent,
East Hartford Public Schools
Anne Marie Mancini
Deputy Superintendent,
East Hartford Public Schools
Stephen Scholand, MD
Infectious Disease Consultant,
MidState Medical Center
Amanda Schiessl, MPP
Project Director,
National Cooperative Agreement
on Clinical Workforce Development
CHC, Inc.
Amy Taylor
VP, Western Region, CHC Inc.
Ruchi Kapoor, RN
Vaccination Staff Nurse, CHCI

20. Thank You!
To learn more about The Path Forward series
WeitzmanLearning.org/the-path-forward
To view previous COVID-19 sessions:
WeitzmanLearning.org/coronavirus